Zobrazeno 1 - 10
of 334
pro vyhledávání: '"Assan, F."'
Autor:
Assan, F., Bottin, L., Francès, C., Moguelet, P., Tavolaro, S., Barbaud, A., de Zuttere, D., Alamowitch, S., Chasset, F.
Publikováno v:
In Annales de Dermatologie et de Vénéréologie March 2022 149(1):3-13
Autor:
Abboud E; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Chrayteh D; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Boussetta N; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Dalle H; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Malerba M; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Wu TD; Institut Curie, PSL University, Université Paris-Saclay, CNRS UAR2016, Inserm US43, Multimodal Imaging Center, Orsay, France., Le Gall M; Proteom'IC facility, Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France., Reelfs O; Department of Life Sciences, University of Bath, Bath, United Kingdom., Pourzand C; Department of Life Sciences, University of Bath, Bath, United Kingdom.; Medicines Development, Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom., Mellett M; Department of Dermatology, University Hospital Zürich (USZ), University of Zürich (UZH), Zürich, Switzerland., Assan F; Laboratory of Genetic Skin Diseases, INSERM U1163, Imagine Institute, Université Paris Cité, Paris, France., Bachelez H; Laboratory of Genetic Skin Diseases, INSERM U1163, Imagine Institute, Université Paris Cité, Paris, France.; Department of Dermatology, Hôpital Saint-Louis APHP, Université Paris Cité, Paris, France., Poupon J; Laboratoire de Toxicologie Biologique, Hôpital Lariboisière, Paris, France. Assistance Publique - Hôpitaux de Paris, AP-HP, Paris, France., Aractingi S; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Service de Dermatologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France., Vaulont S; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Sohier P; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Department of Pathology, Cochin Hospital, Assistance Publique - Hôpitaux de Paris, AP-HP. Centre-Université Paris Cité, Paris, France., Oules B; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.; Service de Dermatologie, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France., Karim Z; Université de Toulouse, INSERM, CNRS, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Paul Sabatier (UPS), Toulouse, France., Peyssonnaux C; Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France. carole.peyssonnaux@inserm.fr.; Laboratory of Excellence GR-Ex, Paris, France. carole.peyssonnaux@inserm.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 07; Vol. 15 (1), pp. 6718. Date of Electronic Publication: 2024 Aug 07.
Autor:
Brenaut E; Dermatology Department, University Hospital of Brest, Brest, France; Laboratoire Interactions Epitheliums Neurones, University of Brest, Brest, France; Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, Paris Est Créteil University (UPEC), Créteil, France. Electronic address: emilie.brenaut@univ-brest.fr., Godin O; Fondation FondaMental, Créteil, France; Translational NeuroPsychiatry Laboratory, Université Paris Est Créteil (UPEC), INSERM U955, IMRB, Paris, France., Leboyer M; Fondation FondaMental, Créteil, France; Translational NeuroPsychiatry Laboratory, Université Paris Est Créteil (UPEC), INSERM U955, IMRB, Paris, France; Department of Psychiatry, Assistance Publique des Hôpitaux de Paris, Hôpital Henri Mondor, Univ Paris-Est-Créteil (UPEC), DMU IMPACT, FHU ADAPT, Creteil, France., Tamouza R; Fondation FondaMental, Créteil, France; Translational NeuroPsychiatry Laboratory, Université Paris Est Créteil (UPEC), INSERM U955, IMRB, Paris, France; Department of Psychiatry, Assistance Publique des Hôpitaux de Paris, Hôpital Henri Mondor, Univ Paris-Est-Créteil (UPEC), DMU IMPACT, FHU ADAPT, Creteil, France., Assan F; INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Institut Imagine, Paris, France., Pignon B; Translational NeuroPsychiatry Laboratory, Université Paris Est Créteil (UPEC), INSERM U955, IMRB, Paris, France; Department of Psychiatry, Assistance Publique des Hôpitaux de Paris, Hôpital Henri Mondor, Univ Paris-Est-Créteil (UPEC), DMU IMPACT, FHU ADAPT, Creteil, France., Sbidian E; Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, Paris Est Créteil University (UPEC), Créteil, France; Department of Dermatology, Hôpital Henri Mondor, Créteil, France.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2024 Jul; Vol. 144 (7), pp. 1657-1660.e9. Date of Electronic Publication: 2024 Jan 20.
Autor:
Astouati Q; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France., Machet T; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France., Houssais C; Rheumatology Department, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINOM), CHU de Brest, Brest, France., Noury JB; Reference Centre for Neuromuscular Diseases AOC, University of Brest, Brest, France.; LBAI, UMR1227, Univ Brest, Inserm, Brest, France., Allenbach Y; Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, APHP, Centre de Référence Maladies Neuro-Musculaires, Sorbonne University, France, Centre de Recherche en Myologie INSERM-Association Institut de Myologie, UMRS 974, Paris, France., Gallay L; Department of Internal Medicine and Clinical Immunology, Edouard Herriot University Hospital, Hospices Civils de Lyon, University Claude Bernard, Lyon, France., Quere B; Rheumatology Department, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINOM), CHU de Brest, Brest, France.; LBAI, UMR1227, Univ Brest, Inserm, Brest, France., Assan F; Laboratory of Genetic Skin Diseases, Institut Imagine, INSERM UMR 1163, Paris., Benveniste O; Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, APHP, Centre de Référence Maladies Neuro-Musculaires, Sorbonne University, France, Centre de Recherche en Myologie INSERM-Association Institut de Myologie, UMRS 974, Paris, France., Broner J; Department of Internal Medicine, University Hospital of Nîmes, France., Duffau P; Internal Medicine Department, Bordeaux University Hospital, FHU ACRONIM, Bordeaux, France. CNRS-UMR 5164 Immuno ConcEpT, Bordeaux University, Bordeaux, France., Espitia A; Department of Internal Medicine, Hôtel-Dieu, CHU de Nantes, France., Grasland A; Department of Internal Medicine, Hôpital Louis Mourier, Université Paris Cité, AP-HP, Colombes, France., Hayem G; Rheumatology Department, Paris Saint-Joseph Hospital, Paris, France., Guern VL; AP-HP, Cochin Hospital, Internal Medicine Department, Centre de référence maladies auto-immunes et systémiques rares d'île de France, Paris, France., Martis N; Department of Internal Medicine, CHU Nice, France. Côte d'Azur University. Mediterranean Centre for Molecular Medicine, Control of gene expression (COdEX), INSERM U1065., Mariampillai K; Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, APHP, Centre de Référence Maladies Neuro-Musculaires, Sorbonne University, France, Centre de Recherche en Myologie INSERM-Association Institut de Myologie, UMRS 974, Paris, France., Nocturne G; Department of Rheumatology, Université Paris-Saclay, AP-HP, Hôpitaux Universitaires Paris-Saclay, Centre for Immunology of Viral Infections and Autoimmune Diseases, INSERM UMR1184, Le Kremlin Bicêtre, France., Mariette X; Department of Rheumatology, Université Paris-Saclay, AP-HP, Hôpitaux Universitaires Paris-Saclay, Centre for Immunology of Viral Infections and Autoimmune Diseases, INSERM UMR1184, Le Kremlin Bicêtre, France., Meyer A; Department of Rheumatology, Strasbourg University Hospital, Centre de Référence des Maladies Auto-immunes Rares, Strasbourg, France., Mulleman D; University of Tours, EA6295 NMNS, Tours, France Department of Rheumatology, CHRU de Tours, Tours, France., Devauchelle-Pensec V; Rheumatology Department, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINOM), CHU de Brest, Brest, France.; LBAI, UMR1227, Univ Brest, Inserm, Brest, France., Collet A; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, F-59000, France.; INSERM, Lille, F-59000, France.; CHU Lille, Institut d'Immunologie, Pôle de Biologie Pathologie Génétique, Lille, F-59000, France., Launay D; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France.; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, F-59000, France.; INSERM, Lille, F-59000, France., Hachulla E; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France., Cornec D; Rheumatology Department, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINOM), CHU de Brest, Brest, France.; LBAI, UMR1227, Univ Brest, Inserm, Brest, France., Guellec D; Rheumatology Department, Centre National de Référence des Maladies Auto-Immunes Rares (CERAINOM), CHU de Brest, Brest, France.; LBAI, UMR1227, Univ Brest, Inserm, Brest, France., Sanges S; CHU Lille, Département de Médecine Interne et Immunologie Clinique, Lille, F-59000, France.; Centre National de Référence Maladies Auto-immunes Systémiques Rares du Nord, Nord-Ouest, Méditerranée et Guadeloupe (CeRAINOM), Lille, F-59000, France.; Health Care Provider of the European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNET), Lille, F-59000, France.; Univ. Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, F-59000, France.; INSERM, Lille, F-59000, France.
Publikováno v:
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Mar 01. Date of Electronic Publication: 2024 Mar 01.
Autor:
Assan, F., Husson, B., Hegazy, S., Seneschal, J., Aubin, F., Mahé, E., Jullien, D., Sbidian, E., D'Incan, M., Conrad, C., Brenaut, E., Girard, C., Richard, M.A., Bachelez, H., Viguier, M.
Publikováno v:
Journal of the European Academy of Dermatology & Venereology; Sep2022, Vol. 36 Issue 9, p1578-1583, 6p
Background/objectives The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 classification criteria for systemic lupus erythematosus system showed high specificity, while attaining also high sensitivity. We hereby
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7308e7867476d1ef57a7e72af71a36ce
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003233
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003233
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Objectives The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 Classification Criteria for systemic lupus erythematosus (SLE) have been validated with high sensitivity and specificity. We evaluated the performan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a7d482231a2907aab6b2f03c3c90b98a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003301
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3003301
Autor:
Johnson, S., Brinks, R., Costenbader, K., Daikh, D., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D., Kamen, D. L., Jayne, D., Cervera, R., Costedoat- Chalumeau, N., Diamond, B., Gladman, D. D., Hahn, B. H., Hiepe, F., Jacobsen, S., Khanna, D., Lerstrom, K., Massarotti, E., Mccune, W. J., Ruiz-Irastorza, G., Sanchez-Guerrero, J., Schneider, M., Urowitz, M. B., Bertsias, G., Hoyer, B. F., Leuchten, N., Tani, C., Tedeschi, S., Touma, Z., Schmajuk, G., Anić, Branimir, Assan, F., Chan, T., Clarke, A. E., Crow, M. K., Czirják, L., Doria, A., Graninger, W., Halda- Kiss, B., Hasni, S., Izmirly, P., Jung, M., Kumanovics, G., Mariette, X., Padjen, Ivan, Pego-Reigosa, J. M., Romero-Diaz, J., Rua- Figueroa, I., Seror, R., Stummvoll, G., Tanaka, Y., Tektonidou, M., Vasconcelos, C., Vital, E., Wallace, D. J., Yavuz, S., Meroni, P. L., Fritzler, M., Naden, R., Dörner, T., Aringer, M.
Background: EULAR/ACR 2019 SLE Classification Criteria were validated in an international cohort. Objectives: To evaluate performance characteristics of SLE classification systems in sex, race/ethnicity, and disease duration subsets. Methods: Sensiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::9793f0d422f6583e4e22588bd96c66f9
https://doi.org/10.1136/annrheumdis-2020-eular.2324
https://doi.org/10.1136/annrheumdis-2020-eular.2324